Application Nr Approved Date Route Status External Links
NDA208711 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Egaten ® Is Indicated For The Treatment Of Fascioliasis In Patients 6 Years Of Age And Older. Egaten ® Tablet Is An Anthelmintic Indicated For The Treatment Of Fascioliasis In Patients 6 Years Of Age And Older.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Triclabendazole TRICLABENDAZOLE ZINC1444556

Comments